glp-1 gastrointestinal obstruction law firm in michigan The Expanding Scope of Receptor Agonists: Six Uses Beyond Diabetes | Current Atherosclerosis Reports glp-1 gastrointestinal obstruction law firm

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began

Pricing $299-449/mo, Semaglutide, tirzepatide, insurance accepted

2023 Apr 6;18(4):e0281150